On June 20, 2019 Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, reported that updated clinical data from an investigator-sponsored Phase 1/2 trial led by Baylor College of Medicine were selected for oral presentation during a plenary session at the upcoming American Association for Cancer Research (AACR) (Free AACR Whitepaper)’s (AACR) (Free AACR Whitepaper) Immune Cell Therapies for Cancer: Successes and Challenges of CAR T Cells and Other Forms of Adoptive Therapy conference (Press release, TapImmune, JUN 20, 2019, View Source [SID1234537188]). The data—which will also be presented in a poster session—will be reviewed by Brandon G. Smaglo, M.D., FACP, Assistant Professor, Medical Director of Hematology/Oncology at the Baylor College of Medicine, Houston, Texas.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Oral Presentation Details
Title: "Targeting pancreatic cancer using nonengineered, multiantigen-specific T cells (TACTOPS)"
Date: Saturday, July 20, 2019
Time (Plenary Session #1): 8:00 a.m. – 10:00 a.m. PST
Location: Hyatt Regency, San Francisco, CA
Poster Presentation Details
Title: "Targeting pancreatic cancer using nonengineered, multiantigen-specific T cells (TACTOPS)"
Date: Saturday, July 20, 2019
Time (Poster Session A): 12:30 p.m. – 2:30 p.m. PST
Location: Hyatt Regency, San Francisco, CA
Investor Event
For those unable to attend the presentations at AACR (Free AACR Whitepaper), Marker will host a live investor event following the conference on Monday, July 22nd at 1:30 p.m. PST in San Francisco featuring Dr. Brandon Smaglo, as well as Marker senior management. A live webcast of the investor presentation will be available in the investors section of the Company’s website at View Source and will be available for replay following the event.